
Results
7
Artificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI’s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.
7 companies
eWeLLLtd
Market Cap: JP¥26.9b
Provides cloud-based electronic power tool for home-based medical care in Japan.
5038
JP¥1,798.00
7D
0.8%
1Y
-29.1%
FINDEX
Market Cap: JP¥19.8b
Offers medical devices in Japan.
3649
JP¥827.00
7D
2.7%
1Y
11.0%
ASO International
Market Cap: JP¥6.5b
Operates in dental orthodontics business in Japan.
9340
JP¥662.00
7D
-1.6%
1Y
12.6%
GENOVA
Market Cap: JP¥9.6b
Engages in the medical platform and smart clinic businesses in Japan.
9341
JP¥557.00
7D
-0.7%
1Y
-23.3%
Hi-CRATESLTD
Market Cap: JP¥4.7b
Engages in the research, development, sales, and support of integrated dental electronic medical record systems.
4172
JP¥2,103.00
7D
-3.9%
1Y
-5.1%
PRISM BioLabLTD
Market Cap: JP¥4.9b
Engages in the research and development of pharmaceuticals using its proprietary drug discovery platform technology, PepMetics Technology.
206A
JP¥134.00
7D
-6.3%
1Y
-47.9%
Renascience
Market Cap: JP¥24.0b
Engages in the development and commercialization of pharmaceuticals and medical devices in Japan.
4889
JP¥1,709.00
7D
11.8%
1Y
-14.1%